Mounjaro
Tirzepatide
Type 2 diabetes
Dual GIP and GLP-1 receptor agonist
Single-dose injection pen
Injection, subcutaneous
Mounjaro is approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes. It is yet to be approved by the FDA for weight loss purposes, but clinical trials have shown promising results for this use. Always follow the prescribed instructions to avoid any potential adverse side effects.
Mounjaro is an FDA-approved injectable prescription medicine manufactured by Eli Lilly that is used to treat Type 2 diabetes. Tirzepatide, the active ingredient of Mounjaro, is also approved for weight loss purposes under the brand name Zepbound.
Although brand-name Mounjaro is not FDA-approved for standalone weight loss treatment, some medical professionals may recommend its use for overweight or obese patients alongside a proper diet plan and regular physical activity. Consult a healthcare provider about the specific dosages for off-label uses and potential risks when considering Mounjaro as a weight-loss medication.
Mounjaro is typically used once weekly, with or without food. It is injected under the skin to help improve blood sugar levels. Always follow the prescribing healthcare provider’s instructions while using Mounjaro.
As with any medication, Mounjaro carries some potential risks of side effects. The most common side effects include nausea, vomiting, and upset stomach. Serious side effects may include a higher risk of thyroid tumors in people with a personal or family history of MTC, pancreatitis, kidney problems, and gallbladder problems. Discuss the possible risks and side effects linked to Mounjaro use with a healthcare provider.
Single-dose injection pen
2.5 mg/0.5 mL
5 mg/0.5 mL
7.5 mg/0.5 mL
10 mg/0.5 mL
12.5 mg/0.5 mL
15 mg/0.5 mL
2.5 mg injected subcutaneously (under the skin) once per week. Then, after four weeks, 5 mg injected under the skin once per week.
Dosage may be increased by 2.5 mg after at least four weeks on the current dose to a maximum dosage of 15 mg once per week.
Mounjaro
10mg/0.5ml 0.5ml pen
Mounjaro
12.5mg/0.5ml 0.5ml pen
Mounjaro
15mg/0.5ml 0.5ml pen
Mounjaro
2.5mg/0.5ml 0.5ml pen
Mounjaro
5mg/0.5ml 0.5ml pen
Mounjaro
7.5mg/0.5ml 0.5ml pen
Mounjaro comes as an injectable solution that is typically administered once per week. Here are the steps to take Mounjaro:
Choose your injection site: The best injection site varies between individuals. Consult your healthcare provider to find the most appropriate location. Common injection sites include the stomach, thighs, or the back of the upper arms.
Clean the injection site: Always clean the area and ensure it’s dry before injecting. Use an alcohol swab to clean the skin and let it dry for a few seconds.
Prepare the Mounjaro single-dose pen: Remove the pen cap and attach a new needle to the pen by screwing it on tightly.
Dial the dose: Turn the dose selector on the pen to the number of units prescribed by your healthcare provider.
Inject Mounjaro: Pinch the skin at the injection site and insert the needle at a 90-degree angle. Press the injection button on the pen until it stops. Hold for 5-10 seconds to ensure the full dose of Mounjaro is administered.
Dispose of the needle safely: Remove the needle from the pen and dispose of it in a designated sharps container. Recap the pen and store it safely until the next use.
Change the location where you inject the medication with each dose. In addition, Mounjaro can be taken with or without a meal. Follow your healthcare provider's advice and the instructions included with the Mounjaro pen for proper use and dosing.
Take the missed dose as soon as possible if it is within 4 days (96 hours) after the missed dose. This will help maintain the effectiveness of the medication.
If more than 4 days have passed since the missed dose, skip the missed dose and proceed with your next dose on the regularly scheduled day. This helps avoid potential complications from taking two doses too close together.
Do not take two doses of Mounjaro within 3 days of each other to avoid possible side effects or an overdose.
Remember to resume your regular once-weekly dosing schedule after taking the missed dose or after skipping it if more than 4 days have passed.
Consult your doctor, pharmacist, or caregiver if you have any concerns or questions about missed doses and the appropriate next steps.
Mounjaro is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC), as the drug may increase the risk of developing thyroid C-cell tumors or thyroid cancer.
Mounjaro should not be used in those who have had serious allergic reactions or hypersensitivity reactions to the drug or its ingredients. Mounjaro may cause serious allergic reactions, which can lead to life-threatening adverse effects.
Patients with a history of kidney complications, such as acute kidney injury or kidney failure, should be cautious when using Mounjaro. The drug may worsen existing kidney conditions or increase the risk of developing kidney problems.
Severe stomach problems and acute pancreatitis: Mounjaro has not been studied extensively in patients with a history of pancreatitis or severe stomach issues. Using the medication in these situations may worsen the existing condition or lead to complications.
Patients with a history of nonproliferative diabetic retinopathy requiring acute therapy, proliferative diabetic retinopathy, or diabetic macular edema have not been studied with the use of Mounjaro. It is important to monitor for the progression of retinopathy if Mounjaro is prescribed.
Mounjaro has been linked to acute gallbladder disease in clinical trials. Patients should be monitored for symptoms of cholelithiasis, and the use of Mounjaro should be reconsidered in patients developing this condition.
Mounjaro carries a boxed warning for the risk of thyroid cancer, the most serious warning issued by the Food and Drug Administration (FDA).
People with a history of gastrointestinal problems, such as slowed emptying of the stomach or trouble digesting meals, should use caution when taking Mounjaro.
The drug may increase the risk of hypoglycemia (low blood sugar) in some individuals. Monitor blood glucose levels regularly while using this medication, especially if you use other antidiabetic drugs like sulfonylureas or insulin.
Mounjaro might not be suitable for individuals with chronic renal failure or a history of worsening chronic renal failure.
Patients with a history of diabetic retinopathy should be cautious, as Mounjaro may worsen this condition.
It is not known whether Mounjaro harms an unborn baby during pregnancy or a breastfeeding child. In addition, Mounjaro may reduce the effectiveness of birth control medications. Consult a healthcare provider for more information if you are pregnant or breastfeeding before starting treatment.
Inform your healthcare provider about any medical conditions, medical history, or other medications you are taking before starting Mounjaro treatment.
Although Mounjaro can be an effective diabetes medication, it may also interact with other drugs and substances. These interactions could potentially lead to unwanted side effects or affect the efficacy of Mounjaro and other medications. Some potential Mounjaro interactions include:
Birth control pills and oral hormonal contraceptives: Mounjaro may affect how well birth control pills work. Discuss the use of birth control pills with a healthcare provider before starting Mounjaro treatment.
Insulin: Combining Mounjaro with insulins, such as insulin glargine or insulin aspart, may increase the risk of hypoglycemia. Monitor blood sugar levels closely and consult a healthcare provider for dosage adjustments when necessary.
Other diabetes medications: Mounjaro may interact with other diabetes drugs such as sulfonylureas or glinides, potentially leading to hypoglycemia. Tell the prescribing doctor about other diabetes medications to avoid dangerous interactions.
GLP-1 receptor agonists: Since Mounjaro belongs to the GLP-1 receptor agonist class of drugs, combining it with other GLP-1 receptor agonists may lead to additive side effects.
This is not a complete list of drug interactions. Consult a healthcare provider about the use of medications while taking Mounjaro.
Side effects of Mounjaro can range from mild to serious. Not everyone will experience the same side effects, and some people might not experience any at all.
Hypoglycemia
Serious allergic reactions
Inflammation of the pancreas (pancreatitis)
Kidney problems, including kidney failure
Severe stomach problems
Vision changes
Gallbladder problems
Nausea
Vomiting
Diarrhea
Constipation
Indigestion
Decreased appetite
Stomach or abdominal pain
It’s recommended to monitor your body's reaction to Mounjaro and report any concerning side effects to your healthcare provider. If you experience severe or persistent symptoms, seek medical help immediately. Symptoms of a serious allergic reaction, such as hives, swelling, and trouble breathing, warrant a medical emergency that requires immediate assistance.
Highlights of prescribing information, FDA (2023)
Tirzepatide, Medline Plus (2022)
Tirzepatide (Mounjaro) for the treatment of type 2 diabetes mellitus, American Family Physician (2023)
Gerardo Sison, Pharm.D., graduated from the University of Florida. He has worked in both community and hospital settings, providing drug information and medication therapy management services. As a medical writer, he hopes to educate and empower patients to better manage their health and navigate their treatment plans.
...(Except Major Holidays)
© 2024 SingleCare Administrators. All Rights Reserved.
* Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
This is a prescription discount plan. This is NOT insurance nor a Medicare prescription drug plan. The range of prescription discounts provided under this discount plan will vary depending on the prescription and pharmacy where the prescription is purchased and can be up to 80% off the cash price. You are fully responsible for paying your prescriptions at the pharmacy at the time of service, but you will be entitled to receive a discount from the pharmacy in accordance with the specific pre-negotiated discounted rate schedule. Towers Administrators LLC (operating as 'SingleCare Administrators') is the authorized prescription discount plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services LLC ('SingleCare') is the vendor of the prescription discount plan, including their website.website at www.singlecare.com. For additional information, including an up-to-date list of pharmacies, or assistance with any problems related to this prescription drug discount plan, please contact customer service toll free at 844-234-3057, 24 hours a day, 7 days a week (except major holidays). By using the SingleCare prescription discount card or app, you agree to the SingleCare Terms and Conditions found at https://www.singlecare.com/terms-and-conditions